Clover Health Investments (CLOV) Treasury Shares (2020 - 2026)

Clover Health Investments has reported Treasury Shares for 6 years, with the latest figure at $94.1 million in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares rose 49.46% year-over-year to $94.1 million; the trailing twelve-month figure through Mar 2026 stood at $94.1 million (up 49.46% YoY), and the FY2025 full-year result was $86.2 million, up 178.1% from the prior year.
• Treasury Shares for Q1 2026 stood at $94.1 million, up from $86.2 million in the prior quarter.
• The five-year high for Treasury Shares was $45.4 million in Q3 2022, with the low at -$1.8 million in Q2 2024.
• Historically, Treasury Shares has averaged $16.2 million across 5 years, with a median of $11.6 million in 2024.
• Annual changes were most pronounced in 2022 — Treasury Shares soared 4327.89% — and 2026, when it jumped 49.46%.
• Clover Health Investments' Treasury Shares stood at $6.5 million in 2022, then jumped by 95.56% to $12.7 million in 2023, then soared by 143.47% to $31.0 million in 2024, then jumped by 178.1% to $86.2 million in 2025, then advanced by 9.16% to $94.1 million in 2026.
• The last three Treasury Shares figures came in at $94.1 million (Q1 2026), $86.2 million (Q4 2025), and $77.0 million (Q3 2025), per Business Quant data.